Evidence map›Paper›PMID 26426784›Full record

ReviewAmerican journal of respiratory and critical care medicine2015

Update in Mycobacterium tuberculosis lung disease 2014.

Paul Elkington, Alimuddin Zumla

Abstract readReview
In one paragraph

Review in American journal of respiratory and critical care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paul Elkington1 National Institute for Health Research (NIHR) Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.ORCID http://orcid.org/0000-0003-0390-0613
Alimuddin Zumla2 Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, United Kingdom; and.

Funding

Targeting matrix metalloproteinases to limit immunopathology in airborne infectioR33AI102239 · NIAID · UNIVERSITY OF SOUTHAMPTON · PI ELKINGTON, PAUL TIMOTHY · 2014 to 2016
$1.1M
NIAID NIH HHS R33 AI102239
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tuberculosis, PulmonaryComorbidityHIV InfectionsHumansTreatment OutcomeTuberculosis, Multidrug-Resistant

Identifiers

PMID26426784
PMCPMC5447301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.